Position in NVO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,397
+$560 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,311
of 1,348 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CKW FINANCIAL GROUP holds $1,202,029 across 12 Drug Manufacturers - General names. NVO ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,232 | $1,074,801 | |
| 2 | AMGN |
Amgen Inc
|
128 | $46,351 | |
| 3 | PFE |
Pfizer Inc
|
1,475 | $35,518 | |
| 4 | BIIB |
Biogen Inc.
|
100 | $21,606 | |
| 5 | ABBV |
AbbVie Inc.
|
30 | $7,549 | |
| 6 | LLY |
ELI LILLY & Co
|
5 | $5,997 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
50 | $2,397 | |
| 8 | AZN |
Astrazeneca PLC
|
12 | $2,275 |
All Filings in NVO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,397 | 50 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,837 | 50 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3 | 50 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4 | 60 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3 | 50 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,083 | 30 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $3 | 30 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $4 | 30 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,282 | 30 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,852 | 30 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||